-
B276089-50mgPotent, selective RARα agonist.
-
B276089-5mgPotent, selective RARα agonist.
-
B345013-100mgProduct Describtion:BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM .BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity. In the in vitro assay using human recombinant
-
B345013-10mgProduct Describtion:BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM .BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity. In the in vitro assay using human recombinant
-
B345013-25mgProduct Describtion:BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM .BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity. In the in vitro assay using human recombinant
-
B345013-50mgProduct Describtion:BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM .BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity. In the in vitro assay using human recombinant
-
B345013-5mgProduct Describtion:BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM .BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity. In the in vitro assay using human recombinant
-
B287441-100mgPotent positive allosteric modulator of δ receptors.
-
B287441-10mgPotent positive allosteric modulator of δ receptors.
-
B287441-25mgPotent positive allosteric modulator of δ receptors.
-
B287441-50mgPotent positive allosteric modulator of δ receptors.
-
B287441-5mgPotent positive allosteric modulator of δ receptors.